Search
for

    Sort by

    Research 661–690 of 1000+

    1. Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata Frontiers in immunology · 2022 · 13 citations
    2. Unexpected Effect of Baricitinib Use: Observation of a Case of Hypertrichosis Indian Journal of Dermatology · 2026
    3. Pharmacologic inhibition of JAK-STAT signaling promotes hair growth Science Advances · 2015 · 159 citations
    4. Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis Life · 2024 · 10 citations
    5. A clinician’s guide to pediatric and adolescent alopecia areata treatments JAAD reviews. · 2024 · 3 citations
    6. PRP for Immune Mediated Alopecias (Alopecia Areata, Alopecia Totalis) 2021 · 1 citations
    7. Stem cell-based therapies for alopecia areata: a narrative review Stem Cell Research & Therapy · 2026
    8. Review of Promising Off-Label Use of Deucravacitinib International Journal of Molecular Sciences · 2025
    9. Abrocitinib in the Treatment of Severe Alopecia Areata in a Pediatric Patient: A Case Report Asian journal of pediatric dermatology. · 2025
    10. Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient Journal of Allergy and Clinical Immunology Global · 2024 · 5 citations
    11. APECED: JAK Inhibition in an Adult Case with Long-Term Follow-up Journal of Human Immunity · 2025
    12. Successful treatment of severe diffuse alopecia areata with abrocitinib Anais Brasileiros de Dermatologia · 2025
    13. Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report Frontiers in Immunology · 2025
    14. Baricitinib (Olumiant) Canadian Journal of Health Technologies · 2024
    15. Baricitinib as a treatment for myasthenia gravis: A case report Neuromuscular Disorders · 2024
    16. Autoinmune Alopecia/Alopecia Areata 2024
    17. Upadacitinib for the treatment of alopecia areata – A case report 2023
    18. The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1 New England Journal of Medicine · 2024 · 71 citations
    19. Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience Journal of Dermatological Treatment · 2023 · 21 citations
    20. Alopecia areata treatment with baricitinib: different relapse phenotypes Journal of Dermatological Treatment · 2024 · 3 citations
    21. 0480 Upadacitinib monotherapy for treatment of pyoderma gangrenosum: A case series Journal of Investigative Dermatology · 2025
    22. Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata Dermatologic Therapy · 2025
    23. S3886 Concurrent Management of Crohn's Ileitis and Alopecia Universalis With Upadacitinib The American Journal of Gastroenterology · 2024
    24. Safety and efficacy of tofacitinib in 97 alopecia areata patients Journal of cosmetic dermatology · 2024
    25. Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus Annals of the rheumatic diseases · 2020 · 16 citations
    26. Baricitinib in pediatric chronic immune thrombocytopenia and associated autoimmune conditions: a case report Frontiers in Pediatrics · 2024
    27. Efficacy of Barictinib As Compared to Conventional Therapy as a Treatment for Alopecia Areata 2024
    28. Application of Baricitinib in Dermatology Journal of inflammation research · 2022 · 14 citations
    29. Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review Indian Dermatology Online Journal · 2024 · 1 citations
    30. 42004 Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study Journal of the American Academy of Dermatology · 2023 · 1 citations